2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Thyroid Neoplasms
9
Hypothyroidism
7
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Laryngeal Neoplasms
1
Infertility, Female
1
Head and Neck Neoplasms
1
Goiter
1
Fatigue
1
Depression
1
Brain Neoplasms
1
Anxiety Disorders
1
Advanced Differentiated Thyroid Gland Carcinoma
1
Interventions
Radiotherapy
4
ferric carboxymaltose
3
Ropivacaine
3
Neoadjuvant Therapy
3
Exercise
3
Ultrasonography
2
Tranexamic Acid
2
Surgical Procedures, Operative
2
Standard of Care
2
Sodium Chloride
2
Sevoflurane
2
Psychiatric Rehabilitation
2
Propofol
2
Proctectomy
2
Preoperative Exercise
2
Oxaliplatin
2
Lymph Node Excision
2
Immunonutrition Diet
2
Hepatectomy
2
Fluorouracil
2
Fibrin Tissue Adhesive
2
Ethanol
2
Dexamethasone
2
Counseling
2
Colectomy
2
Blood Specimen Collection
2
Bevacizumab
2
vapreotide
1
streptococcal preparation 722
1
methyl N-acetylsibirosaminide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Postoperative Complications
×
Thyroxine
×
Clear all
NCT02548715
2022-07-13
LSHT
University of Alberta
Phase 2/3
Withdrawn